355 related articles for article (PubMed ID: 11418462)
1. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells.
Van Tendeloo VF; Ponsaerts P; Lardon F; Nijs G; Lenjou M; Van Broeckhoven C; Van Bockstaele DR; Berneman ZN
Blood; 2001 Jul; 98(1):49-56. PubMed ID: 11418462
[TBL] [Abstract][Full Text] [Related]
2. Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy.
Chung DJ; Romano E; Pronschinske KB; Shyer JA; Mennecozzi M; St Angelo ET; Young JW
J Transl Med; 2013 Jul; 11():166. PubMed ID: 23837662
[TBL] [Abstract][Full Text] [Related]
3. Enhanced dendritic cell antigen presentation in RNA-based immunotherapy.
Kalady MF; Onaitis MW; Padilla KM; Emani S; Tyler DS; Pruitt SK
J Surg Res; 2002 Jun; 105(1):17-24. PubMed ID: 12069496
[TBL] [Abstract][Full Text] [Related]
4. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells.
Van Tendeloo VF; Snoeck HW; Lardon F; Vanham GL; Nijs G; Lenjou M; Hendriks L; Van Broeckhoven C; Moulijn A; Rodrigus I; Verdonk P; Van Bockstaele DR; Berneman ZN
Gene Ther; 1998 May; 5(5):700-7. PubMed ID: 9797876
[TBL] [Abstract][Full Text] [Related]
5. Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.
Schaft N; Dörrie J; Thumann P; Beck VE; Müller I; Schultz ES; Kämpgen E; Dieckmann D; Schuler G
J Immunol; 2005 Mar; 174(5):3087-97. PubMed ID: 15728524
[TBL] [Abstract][Full Text] [Related]
6. Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA.
Michiels A; Breckpot K; Corthals J; Tuyaerts S; Bonehill A; Heirman C; Thielemans K; Aerts JL
Gene Ther; 2006 Jul; 13(13):1027-36. PubMed ID: 16511519
[TBL] [Abstract][Full Text] [Related]
7. Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7.
Dell K; Klein C; Gissmann L
Antivir Ther; 2008; 13(4):495-509. PubMed ID: 18672528
[TBL] [Abstract][Full Text] [Related]
8. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
9. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
[TBL] [Abstract][Full Text] [Related]
10. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.
Tüting T; Wilson CC; Martin DM; Kasamon YL; Rowles J; Ma DI; Slingluff CL; Wagner SN; van der Bruggen P; Baar J; Lotze MT; Storkus WJ
J Immunol; 1998 Feb; 160(3):1139-47. PubMed ID: 9570527
[TBL] [Abstract][Full Text] [Related]
11. Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes.
Strobel I; Berchtold S; Götze A; Schulze U; Schuler G; Steinkasserer A
Gene Ther; 2000 Dec; 7(23):2028-35. PubMed ID: 11175315
[TBL] [Abstract][Full Text] [Related]
12. Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA.
Minami K; Yamaguchi Y; Ohshita A; Kawabuchi Y; Ohta K; Hihara J; Toge T
Oncology; 2005; 69(5):399-407. PubMed ID: 16319511
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell vaccine with mRNA targeted to the proteasome by polyubiquitination.
Hosoi A; Takeda Y; Sakuta K; Ueha S; Kurachi M; Kimura K; Maekawa R; Kakimi K
Biochem Biophys Res Commun; 2008 Jun; 371(2):242-6. PubMed ID: 18423376
[TBL] [Abstract][Full Text] [Related]
14. Efficient genetic modification of murine dendritic cells by electroporation with mRNA.
Van Meirvenne S; Straetman L; Heirman C; Dullaers M; De Greef C; Van Tendeloo V; Thielemans K
Cancer Gene Ther; 2002 Sep; 9(9):787-97. PubMed ID: 12189529
[TBL] [Abstract][Full Text] [Related]
15. In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells.
Van Meirvenne S; Dullaers M; Heirman C; Straetman L; Michiels A; Thielemans K
Mol Ther; 2005 Nov; 12(5):922-32. PubMed ID: 16257383
[TBL] [Abstract][Full Text] [Related]
16. Impact of transfection with total RNA of K562 cells upon antigen presenting, maturation, and function of human dendritic cells from peripheral blood mononuclear cells.
Gao L; Fan HH; Lu HZ; Nie XX; Liu Y; Yang YM; Qian KC; Gao F
Transfusion; 2007 Feb; 47(2):256-65. PubMed ID: 17302772
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.
Ueno H; Tcherepanova I; Reygrobellet O; Laughner E; Ventura C; Palucka AK; Banchereau J
J Immunol Methods; 2004 Feb; 285(2):171-80. PubMed ID: 14980432
[TBL] [Abstract][Full Text] [Related]
18. An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination.
Brabants E; Heyns K; De Smet S; Devreker P; Ingels J; De Cabooter N; Debacker V; Dullaers M; VAN Meerbeeck JP; Vandekerckhove B; Vermaelen KY
Cytotherapy; 2018 Sep; 20(9):1164-1181. PubMed ID: 30122654
[TBL] [Abstract][Full Text] [Related]
19. Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells.
Tuyaerts S; Michiels A; Corthals J; Bonehill A; Heirman C; de Greef C; Noppe SM; Thielemans K
Cancer Gene Ther; 2003 Sep; 10(9):696-706. PubMed ID: 12944989
[TBL] [Abstract][Full Text] [Related]
20. Delivery of Synthetic mRNA Encoding FOXP3 Antigen into Dendritic Cells for Inflammatory Breast Cancer Immunotherapy.
Devi GR; Nath S
Methods Mol Biol; 2016; 1428():231-43. PubMed ID: 27236803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
